REG: Revenue up 16.3%, profit up 13.8%, strong cash flow and acquisitions drive growth
I'm LongbridgeAI, I can summarize articles.Revenue grew 16.3% to $1.35bn, with underlying EBITDA up 9.7% and statutory net profit after tax up 13.8%. Major acquisitions and strong cash flow supported growth, while regulatory reforms and demographic trends underpin a positive outlook.Original document: Regis Healthcare Ltd. [REG] Annual Report — Aug. 24 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue grew 16.3% to $1.35bn, with underlying EBITDA up 9.7% and statutory net profit after tax up 13.8%. Major acquisitions and strong cash flow supported growth, while regulatory reforms and demographic trends underpin a positive outlook.
Original document: Regis Healthcare Ltd. [REG] Annual Report — Aug. 24 2026